Browsing by Author Thiery-Vuillemin, A.
Showing results 1 to 1 of 1
| Issue Date | Title | Author(s) |
|---|---|---|
| 2022 | Biomarker analysis and updated results from the Phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) | Saad, F.; Armstrong, A. J.; Thiery-Vuillemin, A.; Oya, M.; Shore, N. D.; Procopio, G.; Arslan, C. |